83 reports

  • 8.2.1 ANTIVIRALS
  • 7.4 ANTIVIRAL MONOTHERAPY OR COMBINATION THERAPY WITH IMPROVED EFFICACY AND

Oxford University Press, ## Suppl ##(Suppl ##), pp.

  • Antiviral
  • Japan
  • United States
  • Atara Biotherapeutics, Inc.
  • Moderna Therapeutics, Inc.
  • 4.3 Expert Opinion
  • Spain Antiviral Drug Resistance Market Revenue and Forecasts to 2027 (US$ Mn)

Till date, there is no approved antiviral therapy for any of the emerging or re-emerging viral infections.

  • Antiviral
  • World
  • Forecast
  • Market Size
  • Acon Laboratories, Inc

EXECUTIVE SUMMARY ##.

  • Antiviral
  • Therapy
  • APAC
  • Demand
  • Market Shares
  • 6.6 OTHER BRANDED DIRECT-ACTING ANTIVIRALS
  • 6.4 MAJOR BRANDS - SINGLE COMPONENT DIRECT-ACTING ANTIVIRALS

Potent antiviral activities of the direct-acting antivirals ABT-## and ABT-## with three-day monotherapy for hepatitis C virus Genotype ## infection.

  • Antiviral
  • Market Size
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.

The two major HIV subtypes are HIV-## and HIV-##.

  • Antiviral
  • HIV AIDS
  • Therapy
  • World
  • Market Shares

This influence varies from one industry to another, but also from one period of time to another.

  • Antiviral
  • Therapy
  • World
  • Demand

This influence varies from one industry to another, but also from one period of time to another.

  • Antiviral
  • Therapy
  • World
  • Demand

Segments Covered ##) Global Antiviral Drugs Market a.

  • Antiviral
  • APAC
  • United States
  • World
  • Demand
  • CIPLA
  • MERCK & CO.

PRODUCT CATEGORIES: ANTIVIRALS.

  • Antiviral
  • North America
  • World
  • Boehringer Ingelheim GmbH
  • Bristol-Myers Squibb Company
  • Global Hepatitis B Treatment - Drug Pipeline
  • Global Hepatitis B Treatment - Drug Pipeline

Top ## players hold majority of stake in the market ##.

  • Antiviral
  • World
  • Market Size
  • AbbVie Inc.
  • Bristol-Myers Squibb Company

Hepatitis C Therapies Market 2017-2027 ##.

  • Antiviral
  • Hepatitis Treatment
  • Forecast
  • Market Shares
  • Market Size

EXECUTIVE SUMMARY ##.

  • Antiviral
  • Hepatitis Treatment
  • APAC
  • World
  • Market Shares
  • ANTIVIRAL DRUGS MARKET IN EMEA
  • MARKET SIZE AND FORECAST

STRENGTH: ## LOW; ## HIGH F.

  • Antiviral
  • Bristol-Myers Squibb Company
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • ViiV Healthcare Ltd.
  • 6.3 GILEAD

Gilead and GlaxoSmithKline Plc. ##.

  • Antiviral
  • World
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • TREATMENT ACCESS
  • 6.6 CHINA

ANTIVIRAL ACTIVITY OF APRICITABINE IN TREATMENT-EXPERIENCED HIV-##-INFECTED PATIENTS WITH M##V WHO ARE FAILING COMBINATION THERAPY.

  • Antiviral
  • East Asia
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • ViiV Healthcare Ltd.

According to the WHO, cases of viral infections increase by more than ## million each year with around ## million patients already suffering from one of the four Sexually Transmitted Infections (STIs), such as Acquired Immunodeficiency Syndrome (AIDS).

  • Antiviral
  • Therapy
  • United States
  • Forecast
  • HIV TREATMENT DRUGS INDUSTRY ASSESSMENTS

Antiviral therapy suppresses the replication of HIV infection in the body.

  • Antiviral
  • China
  • Co. Shanghai Boeringer Ingelheim Pharmaceutical Co., Ltd.
  • Ltd. Beijing Sanjiu Wandong Pharmaceutical Co., Ltd.
  • UNAIDS
  • ANTIVIRAL EFFICACY OF BARACLUDE COMPARED WITH EPIVIR-HBV
  • ANTIVIRAL EFFICACY OF HEPSERA IN HBEAG-POSITIVE PATIENTS

Like Viread, Epivir-HBV also has antiviral activity against HIV-##, it is branded as Epivir for this indication.

  • Antiviral
  • United States
  • World
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.

Interferon and Antiviral ##. ##. ##. ##.

  • Antiviral
  • Hepatitis Treatment
  • Therapy
  • World
  • Market Size
  • ANTIVIRAL EFFICACY OF BARACLUDE IN EPIVIR-HBV-REFRACTORY PATIENTS
  • ANTIVIRAL EFFICACY OF HEPSERA IN HBEAG-POSITIVE PATIENTS

Like Viread, Epivir-HBV also has antiviral activity against HIV-##, it is branded as Epivir for this indication.

  • Antiviral
  • China
  • World
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • ANTIVIRAL EFFICACY OF BARACLUDE COMPARED WITH EPIVIR-HBV
  • ANTIVIRAL EFFICACY OF BARACLUDE IN EPIVIR-HBV-REFRACTORY PATIENTS

Like Viread, Epivir-HBV also has antiviral activity against HIV-##, it is branded as Epivir for this indication.

  • Antiviral
  • Japan
  • World
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • KEY FINDINGS

CHINA AND THE US ARE LEADING IN COUNTRY-SPECIFIC DRUG DEVELOPMENT. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - Pre-registration ## ## Filing rejected/ Withdrawn Phase III ## ## ## ## Phase II ## ## ## Phase I ## ## ## ## Phase ## IND/ CTA Filed

  • Antiviral
  • Drug Development
  • AbbVie Inc.
  • Gilead Sciences, Inc.
  • Merck & Co., Inc.
  • HIV TREATMENT DRUGS INDUSTRY ASSESSMENTS

ANTIVIRAL THERAPY SUPPRESSES THE REPLICATION OF HIV INFECTION IN THE BODY.

  • Antiviral
  • China
  • Demand
  • Market Size
  • Supply
  • Brazil: Fastest Growing Therapy Classes (ATC 3)

New drugs are classified into one of the categories described in Table ##, below.

  • Antiviral
  • Pharmaceutical
  • Brazil
  • Demand
  • GlaxoSmithKline plc

(USA) ##.

  • Antiviral
  • China
  • Eastern Europe
  • World
  • Market Shares
  • COMMERCIAL ASSESSMENT - CURRENT & FUTURE PLAYERS

COMMERCIAL ASSESSMENT - CURRENT & FUTURE PLAYERS BRISTOL-MYERS SQUIBB SOLD ITS ANTIVIRAL R& D BUSINESS, INCLUDING HIV PIPELINE ASSETS, TO VIIV HEALTHCARE IN DECEMBER 2015.

  • Antiviral
  • United States
  • Gilead Sciences, Inc.
  • Janssen Biotech, Inc.
  • ViiV Healthcare Ltd.

Hepatitis C

4385 5000 3900
  • DIRECT-ACTING ANTIVIRALS TARGET KEY VIRAL NON-STRUCTURAL PROTEINS NECESSARY FOR HCV REPLICATION
  • Pivotal studies supporting approvals of Zepatier

Antiviral Therapy [Epub ahead of print] < DOI> ##. ##/ IMP##< / DOI>.

  • Antiviral
  • European Union
  • Japan
  • North America
  • United States

(USA) ##.

  • Antiviral
  • Hepatitis
  • United States
  • World
  • Market Shares
  • ANTIVIRAL EFFICACY OF BARACLUDE COMPARED WITH EPIVIR-HBV
  • ANTIVIRAL EFFICACY OF BARACLUDE IN EPIVIR-HBV-REFRACTORY PATIENTS

Like Viread, Epivir-HBV also has antiviral activity against HIV-##, it is branded as Epivir for this indication.

  • Antiviral
  • World
  • Forecast
  • Arbutus Biopharma Corporation
  • Gilead Sciences, Inc.
  • BUSINESS SEGMENTATION BY REVENUE
  • GILEAD SCIENCES

It has also signed a contract worth $## billion with Modern Pharmaceuticals for its messenger RNA therapeutics platform for developing new antiviral vaccines and passive immunity therapies.

  • Antiviral
  • Gilead Sciences, Inc.
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • Merck & Co., Inc.